Skip to content

Access to Chiropractic Care During the COVID-19 Pandemic

Access to Chiropractic Care During the COVID-19 Pandemic: a Prospective Comparative Cohort Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04666779
Enrollment
399
Registered
2020-12-14
Start date
2020-12-18
Completion date
2021-09-15
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Access to Chiropractic Care Services

Brief summary

This is a prospective comparative cohort trial taking place during the first year of the Coronavirus-19 (COVID-19) pandemic in Spain. Chiropractic patients throughout Spain were invited to participate independently of the care received, including patients who had stopped visiting their chiropractors since the pandemic hit. The main exposure variable is the access to chiropractic care services, and the degree of this exposure during the months following initial lockdown phase in Spain. Participants will fill an online questionnaire with self-reported outcome-measures.

Interventions

Care provided by chiropractors, based on manual therapy, exercise prescription and patient advice/education/reassurance

Sponsors

University of Birmingham
CollaboratorOTHER
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
CollaboratorOTHER
Université du Québec à Trois-Rivières
CollaboratorOTHER
Real Centro Universitario Maria Cristina
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chiropractic patients with pain, active when lockdown was declared, over the age of 16

Exclusion criteria

* new patients in the clinic after the pandemic hit

Design outcomes

Primary

MeasureTime frameDescription
Tampa Scale Kinesiophobia6 monthsValidated questionnaire (short version 11 items, 0-3: 0=minimal score, 33=maximal score)
Pain interference6 monthsFrom the Brief Pain Inventory (7 items, 0-10: 0= minimal score, 70=maximal score)
Pain Catastrophizing Scale6 monthsValidated questionnaire (short version 4 items, 1-4: 4= minimal score, 16=maximal score)
Pain intensity6 monthsNumerical Rating Scale (0-10, 0=no pain, 10=maximum pain)
Pain duration6 monthsDuration of pain symptoms, PREVIOUS to the study, measured in months (up to 3 months, more than 3 months)
Pain frequency6 monthsRanges: Constant, every day, every week, occasionally
Pain perceived improvement6 monthsCategories: New pain, worsened, no change, improv, gone

Secondary

MeasureTime frameDescription
Fear of Illness and Virus Evaluation6 monthsQuestionnaire (12 items, 1-4: 1=minimal score, 48=maximal score)
General Anxiety Disorder scale6 monthsValidated questionnaire (7 items , 1-3: 1= minimal score, 21=maximal score)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026